Allison C Rosenthal
Overview
Explore the profile of Allison C Rosenthal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Garcia-Robledo J, Valencia-Sanchez C, Knox M, Goodman B, Rosenthal A, Patel B, et al.
Hematol Rep
. 2023 Jan;
15(1):1-8.
PMID: 36648879
Usually used in emergency settings, bedside sonographic measurement of optic nerve sheath diameter can aid in diagnosing elevated intracranial pressure. We report a case of a 26-year-old male hospitalized for...
12.
Loveday T, Duns G, Rimsza L, Rech K, Cook J, Robetorye R, et al.
Blood Adv
. 2022 Oct;
7(6):893-899.
PMID: 36240289
We investigated the clinicopathologic features of 5 follicular lymphomas (FLs) that transformed (tFL) morphologically to diffuse large B-cell lymphomas (DLBCLs) and had a primary mediastinal large B-cell lymphoma (PMBL)-like gene...
13.
Bezerra E, Iqbal M, Munoz J, Khurana A, Wang Y, Maurer M, et al.
Blood Adv
. 2022 Oct;
7(8):1572-1576.
PMID: 36219588
No abstract available.
14.
Chhabra N, Cebak J, Schmitt A, Lal D, Rosenthal A, Taylor C, et al.
Medicine (Baltimore)
. 2022 Aug;
101(32):e30067.
PMID: 35960078
Rationale: Immunoglobulin (Ig) G4-related disease (IgG4-RD) reportedly has a strong relationship with adult-onset asthma and periocular xanthogranuloma (AAPOX) and may be linked to sclerosing mucoepidermoid carcinoma (MEC). We present a...
15.
Borcherding N, Severson K, Henderson N, Ortolan L, Rosenthal A, Bellizzi A, et al.
Blood Adv
. 2022 Apr;
7(3):321-335.
PMID: 35390145
Cutaneous T-cell lymphomas (CTCLs) are a spectrum of diseases with varied clinical courses caused by malignant clonal proliferation of skin-tropic T cells. Most patients have an indolent disease course managed...
16.
Gouni S, Rosenthal A, Crombie J, Ip A, Kamdar M, Hess B, et al.
Blood Adv
. 2022 Mar;
6(9):2757-2762.
PMID: 35240681
Polatuzumab vedotin (PV) is an antibody-drug conjugate targeting CD79b that is approved for patients with relapsed/refractory large B-cell lymphoma (LBCL). Patients who relapse after chimeric antigen receptor (CAR) T-cell therapy...
17.
Brumfiel C, Patel M, Puri P, Besch-Stokes J, Lester S, Rule W, et al.
Curr Treat Options Oncol
. 2021 Sep;
22(11):101.
PMID: 34570278
Choice of therapy in mycosis fungoides is based on both patient- and lymphoma-specific factors, such as disease characteristics, comorbidities, symptoms and effect on quality of life, potential associated toxicities of...
18.
Forero-Forero J, Lengerke-Diaz P, Moreno-Cortes E, Melody M, Rahman Z, Rosenthal A, et al.
Hematol Oncol Stem Cell Ther
. 2021 Sep;
16(2):133-143.
PMID: 34562407
Objective/background: Despite the success of chimeric antigen receptor (CAR) T-cell therapy in patients with aggressive non-Hodgkin lymphoma (aNHL), some patients still fail treatment, and their prognosis is dismal. Methods: We...
19.
Robetorye R, Ramsower C, Rosenthal A, Yip T, Wendel Spiczka A, Glinsmann-Gibson B, et al.
J Hematop
. 2021 Aug;
12(1):3-10.
PMID: 34447482
Diffuse large B-cell lymphomas (DLBCL) represent a clinically heterogeneous group of lymphomas that are classified together based on similarities in morphology and immunophenotype. Gene expression profiling further classifies DLBCL into...
20.
Boudreaux B, Patel M, Brumfiel C, Besch-Stokes J, DiCaudo D, Craig F, et al.
JAAD Case Rep
. 2021 Aug;
15:15-18.
PMID: 34386563
No abstract available.